Serotonin may worsen tinnitus symptoms in new study

New research shows that serotonin, a brain chemical boosted by many antidepressants, can intensify tinnitus. Scientists identified a specific brain circuit in mice that links higher serotonin levels to behaviors mimicking the ringing condition.

A team from Oregon Health & Science University and Anhui University in China published the findings in the Proceedings of the National Academy of Sciences. They used optogenetics to stimulate serotonin-producing neurons and observed increased activity in auditory brain regions, along with tinnitus-like responses in the mice via a modified startle test. The study builds on earlier work from 2017 and matches reports from some patients whose tinnitus worsens on SSRIs.

Labaran da ke da alaƙa

Lab participants show stress and irritability from inaudible infrasound in a scientific study, with visualized low-frequency waves and cortisol monitors.
Hoton da AI ya samar

Study finds infrasound can raise cortisol and irritability even when people can’t hear it

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

A small controlled experiment reported in Frontiers in Behavioral Neuroscience found that exposure to infrasound—ultra-low-frequency vibration below the range of human hearing—was associated with higher salivary cortisol and more negative mood ratings, even though participants could not reliably detect when the infrasound was present.

Researchers have discovered that psychedelic substances suppress visual processing in the brain, leading to hallucinations by drawing on memory fragments. The study, conducted using advanced imaging on mice, shows how slow brain waves shift perception toward internal recall. These findings could inform therapies for depression and anxiety.

An Ruwaito ta hanyar AI

A randomized clinical trial found that 24 minutes of specially designed music paired with auditory beat stimulation significantly lowers anxiety symptoms. Researchers at Toronto Metropolitan University tested various listening durations on 144 adults with moderate anxiety. The 24-minute session provided the strongest benefits.

Researchers at UCLA Health report that delivering transcranial magnetic stimulation (TMS) in an intensive five-day schedule—five sessions per day for five days—was associated with depression symptom improvements comparable to a conventional six-week schedule in a retrospective analysis of 175 patients with treatment-resistant depression. The study also found that some patients who showed little immediate change after the accelerated course improved noticeably in the following weeks.

An Ruwaito ta hanyar AI

A small clinical trial has found that a single dose of the psychedelic drug dimethyltryptamine (DMT) led to rapid and sustained reductions in depression symptoms when combined with therapy. Participants experienced improvements lasting up to six months, with mild side effects reported. The study highlights potential benefits of short-acting psychedelics for treatment-resistant depression.

A study in Molecular Psychiatry used PET imaging with a new tracer to track changes in AMPA-type glutamate receptors in people with treatment-resistant depression receiving ketamine, reporting that region-specific receptor changes were associated with symptom improvement.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi